Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Riccardo Bomben, Francesca Maria Rossi, Filippo Vit, Tamara Bittolo, Antonella Zucchetto, Robel Papotti, Erika Tissino, Federico Pozzo, Massimo Degan, Jerry Polesel, Pietro Bulian, Roberto Marasca, Gianluigi Reda, Luca Laurenti, Jacopo Olivieri, Annalisa Chiarenza, Roberta Laureana, Massimiliano Postorino, Maria Ilaria Del Principe, Antonio Cuneo, Massimo Gentile, Fortunato Morabito, Gilberto Fronza, Agostino Tafuri, Francesco Zaja, Robin Foà, Francesco Di Raimondo, Giovanni Del Poeta, Valter Gattei

Journal: Leukemia 2023;37(4):914-918

PMID: 36807650

Abstract

Address: Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. [email protected].; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; International PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Hematology Unit, Department of Oncology and Hematology, Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena e Reggio Emilia, Modena, Italy.; Division of Ematologia, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.; Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Italy.; Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.; Division of Haematology, University of Tor Vergata, Rome, Italy.; Hematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.; Hematology Unit AO of Cosenza, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.; Hematology Unit AO of Cosenza, Cosenza, Italy.; Hematology Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza, University of Rome, Rome, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.